Page last updated: 2024-12-07

tyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide: RN from Toxlit [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID130144
CHEMBL ID269186
MeSH IDM0172703

Synonyms (13)

Synonym
bdbm50037575
2-amino-pentanedioic acid 5-amide 1-{[1-(1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butyl]-amide}
ylfqpqrfamide
CHEMBL269186 ,
(2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-n-[(2s)-1-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5
(3d)y8fa
y8fa peptide
tyrosyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide
124256-00-4
tyr-leu-phe-gln-pro-gln-arg-phe-nh2
l-phenylalaninamide, l-tyrosyl-l-leucyl-l-phenylalanyl-l-glutaminyl-l-prolyl-l-glutaminyl-l-arginyl
ylfqpqrfa
l-tyrosyl-l-leucyl-l-phenylalanyl-l-glutaminyl-l-prolyl-l-glutaminyl-l-arginyl-l-phenylalaninamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1740819Displacement of [125I][Tyr1]-NPFF from NPFF receptor in rat spinal cord membranes by Cheng-Prusoff analysis2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development.
AID1740820Reversal of morphine-induced analgesia in icv dosed CDF1 mouse assessed as minimum effective dose measured after 15 mins by tail-flick test2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development.
AID146419Binding affinity for NPPF receptor in rat spinal cord membranes using the radioligand [125I]-[Tyr1]NPFF1994Journal of medicinal chemistry, Oct-14, Volume: 37, Issue:21
Structure-activity study of neuropeptide FF: contribution of N-terminal regions to affinity and activity.
AID133092Minimum effective dose able to significantly reverse morphine analgesia in male CDF1 mice by tail-flick test1994Journal of medicinal chemistry, Oct-14, Volume: 37, Issue:21
Structure-activity study of neuropeptide FF: contribution of N-terminal regions to affinity and activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]